Roche Pharmaceuticals A/S: Financial statements 2025
CVR: 25230515
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Roche Pharmaceuticals A/S (CVR 25230515) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 928,824,000 and a net result of DKK 31,319,000 compared with DKK 24,277,000 the year before. That is an increase of 12.3% compared with the year before. The profit margin was 3.4%. Equity in the 2025 report amounted to DKK 195,179,000. The solvency ratio was 44.1%. The company had 97 employees in the financial year.
- Revenue
- DKK 928,824,000
- Gross Profit
- DKK 135,275,000
- Profit/Loss
- DKK 31,319,000
- Equity
- DKK 195,179,000
- Total Assets
- DKK 442,719,000
- Employees
- 97
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 928.8M | 135.3M | 31.3M | 195.2M | 97 |
| 2024 | 827M | 126.7M | 24.3M | 163.9M | 96 |
| 2023 | 761.4M | 145.1M | 36.5M | 139.6M | 97 |
| 2022 | 785.6M | 149.1M | 19.6M | 163M | 103 |
| 2021 | 732.8M | 133M | 16.3M | 143.5M | 110 |
Official annual report
How creditworthy is Roche Pharmaceuticals A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.1482.b" issued by Amgros I/S worth 1,057,200,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.1182.a" issued by Amgros I/S worth 241,000,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Rammeaftale om køb af Itovebi (inavolisib)" issued by Amgros I/S worth 38,500,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.202.a" issued by Amgros I/S worth 24,041,983 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.165.a" issued by Amgros I/S worth 1,566,600,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.167.b" issued by Amgros I/S worth 596,800,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.1053.b" issued by Amgros I/S worth 948,600,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.1050.a" issued by Amgros I/S worth 169,000,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.1054.a" issued by Amgros I/S worth 593,000,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2026 1.1042.b" issued by Amgros I/S worth 337,000,000 DKK.
About Roche Pharmaceuticals A/S
Roche Pharmaceuticals A/S is a Danish company of the type Aktieselskab based in København V, founded in 1970. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ROCHE A/S. MEDICINALVARER & KEMIKALIER. The management consists of Carole Hassoun. The board consists of Isabel Marianne Joerin (chair), Carole Hassoun and Ehab Abdelmoneim Youssef Hassan. The company is owned by Roche Holding AG. The company has 96 employees (2026). In 2025, the company reported revenue of DKK 928,824,000 and a net result of DKK 31,319,000 compared with DKK 24,277,000 the year before. Equity in the 2025 report amounted to DKK 195,179,000.